Live News EQUITY FLASH L impact Oct 27, 2026, 01:55 PM UTC Synact Pharma Expects Full-Study Topline Results in Q2 2027 Synact Pharma expects topline results from its full study during the second quarter of 2027. AB SquawkNews Desk